v3.26.1
STOCKHOLDERS' DEFICIT - Narrative (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 05, 2026
USD ($)
$ / shares
shares
Dec. 23, 2025
USD ($)
D
$ / shares
shares
Sep. 16, 2025
USD ($)
$ / shares
shares
Apr. 04, 2025
USD ($)
shares
Jul. 01, 2024
USD ($)
$ / shares
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Mar. 31, 2026
USD ($)
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
$ / shares
Dec. 31, 2025
USD ($)
shares
Sep. 30, 2025
$ / shares
Mar. 12, 2025
$ / shares
Mar. 05, 2025
$ / shares
Aug. 31, 2024
$ / shares
Aug. 02, 2024
USD ($)
STOCKHOLDERS' DEFICIT                                
Maximum aggregate offering price   $ 10,000,000                            
Legal fees                     $ 85,000          
Exercise Price per Share | $ / shares                         $ 2.25 $ 2.25 $ 1.25  
Gross proceeds from issuance of private placement                 $ 1,410,000              
Sale of stock, Price per share, Percentage       75.00%                        
Threshold business days for computation of trading price       5 days                        
Stock issued during period value new issues               $ 25,000                
Weighted average grant date fair value, Per share | $ / shares           $ 0.38   $ 0.05 $ 0.38 $ 0.1            
Weighted average grant date fair value           2 years   2 years 7 days 2 years 2 years 14 days            
Interest rate, minimum           4.04%   3.96% 4.02% 3.99%            
Lincoln Park Capital Fund                                
STOCKHOLDERS' DEFICIT                                
Stock issued during period value new issues             $ 7,000                  
Unvested Stock Option Awards                                
STOCKHOLDERS' DEFICIT                                
Total unrecognized compensation costs related to nonvested stock option awards           $ 160,000     $ 160,000              
Weighted average period over which unrecognized cost expected to be recognized                 1 year 5 months 4 days              
Restricted Stock                                
STOCKHOLDERS' DEFICIT                                
Total unrecognized compensation costs related to nonvested stock option awards           $ 0     $ 0              
2010 Stock Incentive Plan                                
STOCKHOLDERS' DEFICIT                                
Share based compensation shares reserved for issuance | shares           0     0              
Options forfeited or expired | shares                 949              
Stock Incentive Plan 2019                                
STOCKHOLDERS' DEFICIT                                
Share based compensation shares reserved for issuance | shares           9,532,818     9,532,818              
Options forfeited or expired | shares                 545,391              
Weighted average remaining life                 8 years 9 months 3 days              
Options outstanding | shares           2,632,996     2,632,996   3,100,787          
Common stock reserved for issuance | shares           6,257,501     6,257,501              
Weighted average exercise price of outstanding | $ / shares           $ 0.84     $ 0.84              
The weighted average exercise price of vested and exercisable options | $ / shares           $ 1.2     $ 1.2              
Remaining life                 9 years 2 months 12 days              
Weighted average grant date fair value, Per share | $ / shares                 $ 0.38              
Weighted average exercise price | $ / shares                 $ 0.49              
Share based compensation shares authorized for grants | shares           699,485     699,485              
Forfeitures amount                 $ 26,000              
Common Stock Subject To Outstanding Stock Options | 2010 Stock Incentive Plan                                
STOCKHOLDERS' DEFICIT                                
Weighted average remaining life                 1 year 11 months 1 day              
Options outstanding | shares           12,493     12,493              
Weighted average exercise price of outstanding | $ / shares           $ 19.92     $ 19.92              
Common Stock                                
STOCKHOLDERS' DEFICIT                                
Common stock issued during period new issues (in shares) | shares               354,988                
Stock issued during period value new issues               $ 1,000                
Common Stock | Lincoln Park Capital Fund                                
STOCKHOLDERS' DEFICIT                                
Common stock issued during period new issues (in shares) | shares             20,000                  
Stock issued during period value new issues             $ 1,000                  
Common Stock | Stock Incentive Plan 2019                                
STOCKHOLDERS' DEFICIT                                
Options outstanding | shares           2,632,996     2,632,996              
2026 Private Placement Offering                                
STOCKHOLDERS' DEFICIT                                
Common stock issued during period new issues (in shares) | shares 3,133,333                              
Shares issued price per share | $ / shares $ 0.45                              
Gross proceeds from issuance of private placement $ 1,410,000                              
Expenses payable by the company 58,000               $ 58,000              
Gross cash proceeds 1,000,000                              
Next Round TPV 1,000,000                              
Purchasers TPV $ 1,000,000                              
At The Market Offering Agreement | HC Wainwright Co                                
STOCKHOLDERS' DEFICIT                                
Expenses payable by the company                     $ 147,000          
Aggregate maximum sale price of common stock                               $ 4,450,000
Commission rate                               3.00%
Shares sold | shares           0         12,277,441          
Total gross proceeds                     $ 3,484,000          
2025 Private Placement Offering                                
STOCKHOLDERS' DEFICIT                                
Gross proceeds from issuance of private placement     $ 2,949,000                          
Expenses payable by the company     $ 134,000                          
2025 Equity Line Of Credit Agreement | Lincoln Park Capital Fund                                
STOCKHOLDERS' DEFICIT                                
Maximum aggregate offering price   $ 10,000,000                            
Purchase agreement term   24 months                            
Maximum number of shares per purchase   $ 500,000                            
Threshold percentage of regular purchase price   95.00%                            
Number of lowest common stock | D   3                            
Threshold Trading Days | D   10                            
Accelerated Purchase, Share Purchase Ratio   3                            
Accelerated purchase, Percentage of trading volume   30                            
Accelerated purchase price, Threshold percentage   95.00%                            
Notice period for termination of agreement   1 day                            
Beneficial Ownership Percentage   4.99%                            
Beneficial Ownership Percentage, Threshold   9.99%                            
Notice Period For Increase of Beneficial Ownership   61 days                            
Common stock issued during period new issues (in shares) | shares   824,493                            
Transaction cost   $ 412,000                            
Referral Fees                     84,000          
Legal fees                     $ 28,000          
2025 Equity Line Of Credit Agreement | Share price range greater than $0.75 per share | Lincoln Park Capital Fund                                
STOCKHOLDERS' DEFICIT                                
Offering price | $ / shares   $ 0.75                            
Maximum number of shares per purchase | shares   100,000                            
2025 Equity Line Of Credit Agreement | Share price range from $0.50 per share and greater but below $0.75 per share | Lincoln Park Capital Fund                                
STOCKHOLDERS' DEFICIT                                
Offering price | $ / shares   $ 0.5                            
Maximum number of shares per purchase | shares   75,000                            
2025 Equity Line Of Credit Agreement | Share price range greater than $0.10 per share but below $0.50 per share | Lincoln Park Capital Fund                                
STOCKHOLDERS' DEFICIT                                
Offering price | $ / shares   $ 0.1                            
Maximum number of shares per purchase | shares   50,000                            
2024 Private Placement Offering                                
STOCKHOLDERS' DEFICIT                                
Common stock issued during period new issues (in shares) | shares         1,248,527                      
Gross proceeds from issuance of private placement         $ 1,909,000                      
Expenses payable by the company         $ 72,000                      
2025 Lincoln Park Agreement                                
STOCKHOLDERS' DEFICIT                                
Common stock issued during period new issues (in shares) | shares           20,000     20,000              
Stock issuance costs           $ 0     $ 0              
Remaining availability under equity line of credit agreement amount           9,994,080     9,994,080              
Gross proceeds           $ 7,000     $ 7,000              
June 2026 Warrants                                
STOCKHOLDERS' DEFICIT                                
Exercise Price per Share | $ / shares           $ 0.75     $ 0.75              
June 2026 Warrants | 2026 Private Placement Offering                                
STOCKHOLDERS' DEFICIT                                
Class of warrant or right number of securities called by warrants or rights | shares 4,230,000                              
Exercise Price per Share | $ / shares $ 0.75                              
September 2025 Warrants | 2025 Private Placement Offering                                
STOCKHOLDERS' DEFICIT                                
Shares issued price per share | $ / shares     $ 0.45                          
Exercise Price per Share | $ / shares     $ 0.75                          
March 2025 Warrants                                
STOCKHOLDERS' DEFICIT                                
Offering price | $ / shares                         0.5      
Exercise Price per Share | $ / shares                       $ 0.35 $ 0.25      
Warrants expire year                         5 years      
July 2024 Warrants | 2024 Private Placement Offering                                
STOCKHOLDERS' DEFICIT                                
Shares issued price per share | $ / shares         $ 1.53                      
Exercise Price per Share | $ / shares         $ 2.25                      
Purchase Agreement                                
STOCKHOLDERS' DEFICIT                                
Transaction cost       $ 214,000                        
Sale of stock       $ 2,000,000                        
Restricted common stock, shares | shares       354,988                        
Restricted common stock, value       $ 25,000                        
Purchase Agreement | 2025 Private Placement Offering                                
STOCKHOLDERS' DEFICIT                                
Common stock issued during period new issues (in shares) | shares     6,550,000                          
2024 At the Market Offering Agreement                                
STOCKHOLDERS' DEFICIT                                
Total gross proceeds                 $ 4,388,000              
Stock issued during period value new issues                 $ 62,000